Source: Korea Biomedical Review

QuantaMatrix: QuantaMatrix to launch Alzheimer's early detection test as non-reimbursable service

QuantaMatrix, a Korean in-vitro diagnostics company, will release its Alzheimer's early detection test, AlzPlus, as a non-reimbursable service starting next Monday. The launch follows a notification issued by the Ministry of Health and Welfare after an amendment to the provisional approval of the Ne

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
SungHoon Kwon's photo - President & CEO of QuantaMatrix

President & CEO

SungHoon Kwon

CEO Approval Rating

82/100

Read more